1. Introduction
===============

Natural products, and in particular secondary metabolites, have been the focus of study in many marine macroalgae. Seaweeds interact with their environment utilizing a rich variety of secondary metabolites \[[@b1-marinedrugs-09-02438]--[@b4-marinedrugs-09-02438]\]. These chemical compounds have no explicit role in the internal metabolism of the organisms \[[@b1-marinedrugs-09-02438],[@b5-marinedrugs-09-02438],[@b6-marinedrugs-09-02438]\] but serve as defense mechanisms against grazers, competitors, fouling organisms and pathogens \[[@b7-marinedrugs-09-02438]--[@b9-marinedrugs-09-02438]\]. The compounds are localized in specialized cells, have relatively low molecular weights (\<3000 Daltons), are structurally diverse, often halogenated, and exist in low abundance (often \<1% of total carbon) \[[@b1-marinedrugs-09-02438],[@b2-marinedrugs-09-02438],[@b6-marinedrugs-09-02438],[@b10-marinedrugs-09-02438]--[@b12-marinedrugs-09-02438]\].

Secondary metabolites have drawn wide attention because of their pharmaceutical potentials, chemotaxonomic and ecological importance \[[@b13-marinedrugs-09-02438]--[@b16-marinedrugs-09-02438]\]. Macroalgae produce a wide range of compounds such as terpenes, phenols, fatty acids, lipopeptides, amides, alkaloids, terpenoids, lactones, pyrroles and steroids \[[@b9-marinedrugs-09-02438],[@b15-marinedrugs-09-02438],[@b17-marinedrugs-09-02438]\]. Red seaweeds belonging to the family Rhizophyllidaceae have been found to be especially rich in secondary metabolites, harboring a variety of halogenated monoterpenes. The tropical, Indo-Pacific genus *Portieria* (synonyms *Chondrococcus* and *Desmia*), is a prolific source of these halogenated compounds \[[@b11-marinedrugs-09-02438],[@b12-marinedrugs-09-02438],[@b18-marinedrugs-09-02438]--[@b24-marinedrugs-09-02438]\], about 80 of which have been isolated ([Table S1](#s1-marinedrugs-09-02438){ref-type="supplementary-material"}). Among the most interesting of these compounds is halomon, a monoterpene with anti-tumor properties, isolated from samples collected in Batanes, Philippines \[[@b22-marinedrugs-09-02438],[@b23-marinedrugs-09-02438]\]. However, the inconsistent availability of this compound from natural populations prevented further drug development.

Previous studies have mainly focused on discovery and pharmaceutical potentials of chemical compounds in *P. hornemannii*. Only a few studies have addressed inter- or intraspecific variation in secondary metabolite composition. Puglisi and Paul \[[@b25-marinedrugs-09-02438]\] tested the carbon/nutrient hypothesis, which postulates that the secondary metabolites produced by a certain alga are dependent on the nutrient availability. They found that variation of ochtodene concentrations in *P. hornemannii* cannot be attributed to nitrogen and phosphorus availability but suggested instead that light was a contributing factor. Matlock *et al.* \[[@b24-marinedrugs-09-02438]\] demonstrated strong site-to-site differences, variation within populations, and limited evidence for temporal variation in apakaochtodene levels. Some authors have emphasized the necessity to genotype the organisms in order to better understand the mechanisms that regulate the production of specific natural products \[[@b5-marinedrugs-09-02438],[@b26-marinedrugs-09-02438]--[@b28-marinedrugs-09-02438]\].We found evidence for a large number of cryptic species within *Portieria* in the Philippines \[[@b29-marinedrugs-09-02438]\], but the effect of intraspecific genetic variation in relation to secondary metabolites has not been tested to date.

This study aims to understand if non-polar secondary metabolites of *Portieria* plants vary quantitatively or qualitatively between cryptic species and among life stage within species. We employed metabolite fingerprinting and multivariate analyses of chromatograms of extracts of samples collected in the Philippines. The large number of compounds produced by *Portieria*, the lack of commercial standards and the scarcity of compound identification resources (mass spectral databases) dedicated to marine secondary metabolites makes metabolite fingerprinting the most feasible analytical method to define variation between cryptic species and among life-history stages within species. In contrast to target analysis, metabolite fingerprinting does not separate individual metabolites, but instead compares spectra of whole extracts using multivariate statistics \[[@b30-marinedrugs-09-02438]\]. Metabolite fingerprinting is particularly useful for rapid classification of samples \[[@b31-marinedrugs-09-02438]\]. Our specific aims were to evaluate: (1) if there is variation of non-polar secondary metabolites between the gametophyte and tetrasporophyte life-history stages of *Portieria*, (2) if metabolite variation is due to the presence of phylogenetically distinct cryptic species, and (3) if patterns of variation are observed on a geographical and temporal level.

2. Results and Discussion
=========================

2.1. Cryptic Diversity
----------------------

Phylogenetic analyses of 152 *cox*2--3 sequences revealed 12 clades of closely related sequences, preceded by long well-supported branches. Seven lineages include specimens from Batanes and five clades are restricted to the Visayas ([Figure 1](#f1-marinedrugs-09-02438){ref-type="fig"}). These clades will further be regarded as species. Details on cryptic diversity and species delimitation are reported in Payo \[[@b29-marinedrugs-09-02438]\].

2.2. Identification of Compounds in Non-Polar Extracts
------------------------------------------------------

Owing to the lack of standard compounds and public repositories of mass spectral data specific to marine metabolites, the identity of the compounds was investigated only by comparing the mass spectra and the Kovats retention indices to those deposited in publicly available databases (MassBase, Pherobase, Lucero Library and the free limited NIST database in the MS Search Program and AMDIS). Identifications were based on a minimum of 80% similarity of mass fragments. Using a retention index calculator \[[@b32-marinedrugs-09-02438]\], plant volatiles with the nearest Kovats Index (KI) to that of the compounds in the samples were retrieved. The KI used for compound identification is based on a DB5 capillary column similar to the non-polar, low bleed HP-5MS column used for GC/MS in this study. The Lucero KI based identification was verified with the mass spectra and KIs listed in Pherobase. Comparison with mass spectra of compounds found in *Portieria* in the literature \[[@b11-marinedrugs-09-02438],[@b12-marinedrugs-09-02438],[@b33-marinedrugs-09-02438]\] did not reveal any positive identification. Examination of mass fragments did not show any similarity of components with that of halomon's mass spectral fragments as reported by Egorin *et al.* \[[@b33-marinedrugs-09-02438]\].

2.3. Metabolite Fingerprinting
------------------------------

### 2.3.1. Variation Between Life Stages

Plants used for this study belonged to a single species V1B ([Figure 1](#f1-marinedrugs-09-02438){ref-type="fig"}) and were collected on the same day from a single site in Bantayan, Dumaguete. A total of 202 non-polar compounds were detected from gametophytes and tetrasporophyte samples by GC-MS ([Table S2](#s2-marinedrugs-09-02438){ref-type="supplementary-material"}). Using an external standard and the databases, the first peak of each sample (RT = 6.18 min) was confirmed as β--myrcene ([Figure 2a](#f2-marinedrugs-09-02438){ref-type="fig"}). Of the remaining compounds, only 11% (22) were identified using NIST and MassBase. Based on the NIST and MassBase identifications, five compounds were monoterpenes. Examination of the patterns of parent ions showed ten halogenated compounds containing one Cl or one Br. Two hundred compounds had a KI ranging 993--1969. Some peaks with succeeding retention times shared the same KI but had a different mass spectra composition. NIST and MassBase did not share the same identification of peaks except for β-myrcene.

KI for the last two peaks were not computed since it occurred later than the last alkane standard (C20 at 31.226 min) that was used for KI calculation. We also explored the potential of the Lucero library and Pherobase to identify compounds that *Portieria* might have in common with land plants. The Lucero library retrieved the nearest KIs of plant volatiles. Some of these identifications were verified at Pherobase, but mass spectra composition of the unidentified peaks was not similar to the spectra of the compound name retrieved from the database. Furthermore, we also tried to retrieve compounds with a certain KI and examined the corresponding spectra. β-Myrcene has a KI of 993.543 in this study. Pherobase listed 991 and 994 as KIs for β-myrcene in a DB5 column. Nine compounds listed in the database have a KI of 993.

The Lucero library lists KI 993 for β-myrcene. With the large number of metabolites retrieved, this method of verification proved cumbersome especially since Pherobase currently does not allow automated mass spectral and KI comparison. Of the 202 compounds detected, 155 compounds were present in the female samples, 102 in male plants and 106 in tetrasporophytes ([Figure 3a](#f3-marinedrugs-09-02438){ref-type="fig"}). There were 55 compounds that were shared by all life stages. Sixty-three compounds were found exclusively in female gametophyte extracts, 15 in male gametophyte extracts, and 18 in tetrasporophyte extracts. There were 14 compounds common to male and tetrasporophyte extracts. The male and female gametophyte shared 18 compounds while female and tetrasporophyte shared 19 compounds. A precursor compound of the monoterpenes, myrcene, was detected in all of the life stages but not in all replicates.

We applied a principal component analysis (PCA) on the standardized relative abundances to determine if metabolites differ among life stages ([Figure 4a](#f4-marinedrugs-09-02438){ref-type="fig"}). The matrix contained 202 compounds (active variables) and ten samples (active cases: six female gametophytes, two male gametophytes, and two tetrasporophytes). All samples were collected on the same day from a single site, and belong to a single species. [Figure 4a](#f4-marinedrugs-09-02438){ref-type="fig"} shows the projection of the cases on the factor plane. Factor 1 and factor 2 accounts for 20.42% and 14.37% of the variation, respectively. Factor 1 clearly discriminated the male gametophytes from the others, whilst the female gametophytes and tetrasporophytes, although separated, were more closely aligned. Factor 2 does not discriminate between life stages but points towards additional variation within life stages.

### 2.3.2. Variation Between Cryptic Species

A total of 67 compounds were detected from nine samples (three technical replicates) by GC-MS ([Table S3](#s3-marinedrugs-09-02438){ref-type="supplementary-material"}). These samples belonged to the five species B8, B5, B21, B33 and B35, as determined by DNA sequence analysis. A sample consists of pooled extract of eight individuals belonging to one species as verified by DNA analysis. β-Myrcene was not detected in any of the samples ([Figure 2b](#f2-marinedrugs-09-02438){ref-type="fig"}). Unfortunately the three databases used (NIST, MassBase, Lucero library) did not give identical identifications of compounds. NIST identified four compounds appearing at different times as 2,2-dimethyl-3-hexanone. Comparison of mass spectra with MassBase resulted in the retrieval of straight and branched alkanes and alkenes. Compounds with retention times from 8.11 to 30.69 min had retention indices from 1065 to 1965. No KIs were computed for the rest of the compounds. Comparison of computed KIs with those in the Lucero library indicated compounds from these samples contained monoterpenes, sesquiterpenes, esters, fatty acids and alcohols. NIST, MassBase and the Lucero databases did not share the same identification of compounds. Visual examination of parent ions showed only two compounds to be halogenated containing either one Cl or one Br.

The number of compounds detected varied between the five species ([Table 1](#t1-marinedrugs-09-02438){ref-type="table"}) and among biological replicates. Species B35 had the highest number of compounds detected (60/67), species B33 contained 51/67 compounds detected, species B8 and B5 both had 57/67 compounds detected and species B21 had the least number of compounds (49/67). There were 21 compounds that were detected in all nine samples, while 33 compounds were present in all five species.

To detect distinct groupings, we conducted a PCA based on the standardized relative abundances of the nine samples using the 67 compounds as variables ([Figure 4b](#f4-marinedrugs-09-02438){ref-type="fig"}). The first principal axis accounted for 27.4% of the variance while the second 16.0%. Plotted scores from the PCA did not show distinct interspecific clusters. The largest variation was displayed by specimens belonging to species B5.

### 2.3.3. Spatial and Temporal Variation

Six sites in the Visayas (Sawang, Pagubagubaan, Dapdap, Siaton, Liloan and Bantayan (Dumaguete); *n* = 44) were sampled from 2007 to 2009 and investigated using Spectconnect to determine if seasonality or geography explained the variation in secondary metabolites. A total of 33 compounds were detected from these samples ([Table S4](#s4-marinedrugs-09-02438){ref-type="supplementary-material"}), however, β-myrcene was not detected ([Figure 2c](#f2-marinedrugs-09-02438){ref-type="fig"}). As in previous datasets, the three databases (NIST, MassBase, Lucero library) used did not give identical identifications of compounds. Comparison of mass spectra with MassBase resulted in the retrieval of eleven compounds, most likely straight and branched alkanes and alkenes. Many of the peaks detected eluted later than the standard, icosane (C20), hence were not included. Comparison of computed RIs with those in Lucero library retrieved the following compound classes: monoterpenes, sesquiterpenes, esters and fatty acids. NIST library identified two compounds, 3-hexanone, 2,2-dimethyl- and disilane. No halogenated compounds were detected.

PCA was conducted using the standardized relative abundance file generated by Spectconnect (*n* = 44) using the 33 compounds as variables ([Figure 5a](#f5-marinedrugs-09-02438){ref-type="fig"}). The first and second PCs accounted for 17.87% and 17.78% of the variance, respectively. No clear groupings could be deduced based on species, sampling period, or sampling site. Most of the samples clumped except for one Siaton and two Bantayan samples, which were clearly separated from the rest. A PCA excluding these three samples slightly spread the rest of the samples but likewise did not show any recognizable clusters ([Figure 5a](#f5-marinedrugs-09-02438){ref-type="fig"}). A separate PCA analysis was conducted on samples belonging to the same species, V32, from Sawang, Pagubagubaan, and Liloan ([Figure 5b](#f5-marinedrugs-09-02438){ref-type="fig"}). The first and second PCs accounted for 21.36% and 14.96% of the variance, respectively. Again, no clusters based on site or period of collection were detected.

2.4. Patterns of Secondary Metabolite Distribution
--------------------------------------------------

Distribution of secondary metabolites in marine macroalgae exhibit macroscale and microscale patterns \[[@b34-marinedrugs-09-02438]\]. Macroscale patterns include global patterns within or across algal taxa, patterns within a specific habitat, and patterns correlated with biotic and abiotic factors. Microscale patterns are related to molecular and biochemical processes within an algal thallus, the spatial distribution of compounds within an algal thallus and temporal responses (short- and long-term responses). In *Portieria* neither macro- nor microscale patterns of secondary metabolite variation have been fully explored.

Although three decades of studies have been dedicated to the isolation of new compounds only two have investigated the variation of these, specifically ochtodene and apakaochtodene A and B \[[@b24-marinedrugs-09-02438],[@b25-marinedrugs-09-02438]\]. However, a possible drawback related to these studies is the fact that individual compounds are not mutually independent but are linked via biological pathways as is the case for β-myrcene, which is the likely precursor of many monoterpenes \[[@b35-marinedrugs-09-02438]\], and whose presence influences the presence or absence of other halogenated monoterpene components. Hence in order to understand general or specific metabolite patterns, knowledge of the presence and absence of progenitor compounds is essential. The present study has successfully described the variation of the non-polar secondary metabolites of *Portieria* on a macroscale level using metabolite fingerprinting.

Reports on intraspecific variation of secondary metabolites in macroalgae have been based on variations within individuals, between individuals of a population and among geographically isolated populations \[[@b36-marinedrugs-09-02438],[@b37-marinedrugs-09-02438]\]. Our results suggest substantial intraspecific variation among the life-history stages of *Portieria*. Male gametophytes form a clearly distinct group, while a partial discrimination was detected between female gametophytes and tetrasporophytes ([Figure 4a](#f4-marinedrugs-09-02438){ref-type="fig"}). Furthermore, our results show that female gametophytes are chemically richer in terms of the number of secondary metabolites ([Figure 3a](#f3-marinedrugs-09-02438){ref-type="fig"}), possibly providing protection to the carposporophyte from grazers. Many of the compounds detected appear to occur exclusively to a certain life-history stage while a relatively small group of compounds is shared among life-history stages. Similarly, male gametophytes of *Asparagopsis armata* were found to have lower concentration of the secondary metabolite bromoform compared to female gametophytes \[[@b37-marinedrugs-09-02438]\]. It has also been observed that the carposporophyte phase of *A. armata* was the least consumed life-history phase by the seahare, *Aplysia parvula* \[[@b37-marinedrugs-09-02438]\]. Likewise, in the brown alga *Dictyota menstrualis*, female gametophytes were found to produce more diterpenes compared to the other life-history stages \[[@b38-marinedrugs-09-02438]\].

Comparative analyses of the five cryptic species from Batanes (B5, B21, B33, B35, and B8) showed variation between, as well as within species ([Figure 4b](#f4-marinedrugs-09-02438){ref-type="fig"}). Intraspecific variation is even more pronounced in the Visayas dataset ([Figure 5](#f5-marinedrugs-09-02438){ref-type="fig"}). Neither species specific nor spatio-temporal patterns were evident.

In addition, a separate PCA including only specimens of species V32 ([Figure 3b](#f3-marinedrugs-09-02438){ref-type="fig"}) did not elucidate patterns based on collection site or period. The results suggest that life history related variations combined with microscale factors have a large influence on the variation within *Portieria* species. Pelletreau and Targett \[[@b34-marinedrugs-09-02438]\] pointed out that the existence of inducible and activated defenses complicates the search for universal patterns of secondary metabolites and continues to highlight the importance of localized phenomena. We conducted a preliminary grazing experiment in outdoor flow-through aquaria to assess the influence of the herbivore (*Aplysia*) on the production of metabolites in *Portieria*. However, these efforts were beset by two factors: death of plants due to high water temperature and continuous development of microscopic *Aplysia* larvae on field collected plants undergoing acclimatization. Future grazing experiments will attempt to eliminate these factors. In addition more extensive sampling should confirm the patterns observed during the present study.

Finally, there was difficulty in achieving unequivocal identification of compounds in this study unveiling the need for mass spectral and KI databases dedicated solely to marine secondary metabolites. Such repositories will assist in the identification of previously reported compounds for investigations mainly focused on rapid detection and understanding of chemical patterns in marine organisms. In doing so, future studies will not just be focused in isolating and naming novel compounds as had been the trend in *Portieria* but will also seek to answer questions of biological or ecological relevance. Furthermore, the presence of cryptic species in *Portieria* highlights the need to genotype organisms ensuring that correct species identification is correlated with metabolite fingerprint, enabling more targeted approaches in future studies.

3. Experimental Section
=======================

3.1. Collection and Storage
---------------------------

Field samplings were performed at different periods from several sites in the Philippines ([Figure S1](#s5-marinedrugs-09-02438){ref-type="supplementary-material"}). Plants were collected by snorkeling and SCUBA, diving depths ranging from 1--20 m. For secondary metabolite characterization of the different life-history stages of *Portieria*, plants were collected randomly from Bantayan near Dumaguete ([Figure S1c](#s5-marinedrugs-09-02438){ref-type="supplementary-material"}) on December 29, 2009. To allow both chemical characterization and life-history stage verification plants were blotted dry and stored over silica.

Plants for secondary metabolites analysis between species were collected from four sites in Batanes (Basco, White Beach, Coral, and in Chavayan) ([Figure S1a,b](#s5-marinedrugs-09-02438){ref-type="supplementary-material"}) on April 23--26, 2009. Plants were preserved in 95% ethanol in the field and stored at −23 °C afterwards. Sampling for seasonal and spatial comparison of secondary metabolites were conducted from six sites in the Central Visayas (Dapdap, Siquijor, Siquijor; Pagubagubaan, San Juan, Siquijor; Sawang, San Juan Siquijor; Bantayan, Dumaguete, Negros Oriental; Siaton, Negros Oriental; Liloan, Santander, Cebu ([Figure S1a,c](#s5-marinedrugs-09-02438){ref-type="supplementary-material"}) from 2007 to 2009. For the first four sites, plants were collected on a monthly basis when present and when abundant enough to afford a good amount for extraction. For sites close to the Silliman Marine Laboratory, plants were immediately packed and stored at −23 °C upon arrival. When immediate freezing was not possible, plants were preserved in 95% ethanol in the field and stored at −23 °C. Frozen plants were rinsed in freshwater or in ethanol and blotted dry.

As *Portieria* cannot be distinguished morphologically, species identification was based on DNA sequence data (see below). For DNA characterization, thallus clippings were collected from specimens and stored in silica while in the field.

3.2. Extraction
---------------

### 3.2.1. Life-History Stages Comparison

*Portieria* has a tri-phasic isomorphic life history which includes free-living haploid male and female gametophytes, a diploid carposporophyte attached to and dependent on the female gametophyte, and a free-living diploid tetrasporophyte. Silica-dried specimens were examined under the microscope and segregated into different life-history stages (male gametophytes, female gametophytes, and tetrasporophytes). Biological replicates, each about 1 gram dry weight, were prepared for every life-history stage. Tissues were ground using mortar and pestle, dissolved in 6 mL dichloromethane (DCM) containing 50 μg·mL^−1^ naphthalene, and vortexed for a few seconds. The DCM extracts were allowed to stand at room temperature for 24 h in screw-cap tubes. The extracts were decanted and transferred to air tight screw-cap tubes and stored at −23 °C. The tissues were steeped in DCM for another 24 h. First and second extracts of a sample were pooled and filtered using Whatman GF/C. The combined extracts were loaded onto pre-conditioned SPE tubes containing 10 g of silica (Silicycle SiliaFlash^®^ G60, 60--200 μm, 60 Å). Non-polar compounds were eluted using 12 mL hexane. The eluate was concentrated to 0.5 mL under N~2~ gas. Three 100 μL replicates were taken from this stock and used as technical replicates in the GC-MS analysis.

### 3.2.2. Species Comparison

The samples were extracted individually. Tissue was ground using a mortar and pestle and extracted twice in 6 mL DCM overnight. Extracts were pooled, loaded onto 2 g silica and eluted using 6 mL of hexane. Eluates of eight samples belonging to the same species, approximately weighing 10--26 g, were pooled and evaporated down to 100 μL. To assess consistency in the GC-MS analyses, three technical replicates were prepared for each sample.

HPLC solvents for extraction and chromatography (DCM and *n*-hexane) were sourced from Mallinckrodt or HiperSolv Chromanorm). Naphthalene (Fisher) and β-myrcene (Sigma) were used as internal and external standards, respectively.

### 3.2.3. Seasonal and Spatial Comparison

For seasonal analysis, plant material was ground using mortar and pestle. Twenty grams of ground material was extracted in 20 mL DCM for 24 h at room temperature. The material was extracted a second time in 20 mL DCM and the extracts were pooled. To measure the amount of green oil that was generated, one of the two pooled extracts was evaporated to dryness using nitrogen. The oil was weighed and redissolved in 20 mL DCM. The other extract was evaporated down to 20 mL. Both extracts were loaded in SPE columns containing 10 g of silica (Silicycle SiliaFlash^®^ G60, 60--200 μm, 60 Å). Non-polar compounds were eluted from the column with 20 mL hexane and again reduced to 100 μL. A separate aliquot of ground plant tissue was used to determine dry mass.

3.3. Phylogenetic Analysis
--------------------------

Assignment of the sampled specimens to cryptic species was based on phylogenetic analysis of the mitochondrial *cox*2--3 spacer region. The phylogeny includes specimens collected from five sites (Basco, Chanaryan, Coral, Mahatao, Chavayan) in Batanes and six sites (Dapdap, Siquijor; Sawang, San Juan, Siquijor; Pagubagubaan, San Juan, Siquijor; Malo, Siaton; Bantayan, Dumaguete; Liloan, Santander) in the Visayas, Philippines. Species delineation follows the rational outlined in Payo *et al.* \[[@b29-marinedrugs-09-02438]\]. DNA extraction, PCR amplification, sequencing and sequence alignment were performed as described in Payo *et al.* \[[@b29-marinedrugs-09-02438]\].The alignment of 152 *Portieria* sequences was 345 bp long. Bayesian inference (BI) of phylogeny was performed using MrBayes v3.1.2 \[[@b39-marinedrugs-09-02438]\] under a GTR + I + Γ model as determined by jModelTest \[[@b40-marinedrugs-09-02438]\]. BI analyses consisted of two parallel runs of three incrementally heated chains and one cold chain each, and 3 million generations with sampling every 1000 generations. A burnin value of 750 was determined using TRACER V1.4 \[[@b41-marinedrugs-09-02438]\].

3.4. Metabolite Analysis, Data Processing and Multivariate Analysis
-------------------------------------------------------------------

### 3.4.1. GC-MS Analysis

GC-MS analyses of the non-polar eluates were performed using an Agilent 6890 gas chromatograph and Agilent 6973 mass selective detector. Sample injection volume was 1 μL. Split injection with a split ratio of 20:1 was used. The carrier gas was helium with a total flow rate of 72.7 mL·min^−1^ and 26.20 psi column head pressure. Compounds were separated using a 30 m × 0.25 mm HP-5 MS non-polar capillary column (Hewlett-Packard, 5% phenyl methyl siloxane, 0.25 μm thickness) for a run time of 67 min. under the following oven temperature program: 50 °C initial held for 2 min, then increased at a rate of 5 °C·min^−1^ to 300 °C, held for 15 min. The spectrometers were run in electron-impact mode with ionization energy of 70 eV and an ion source temperature ranging 230--250 °C. The scan range was set to detect masses 50--500 amu.

### 3.4.2. GC-MS Data Processing

The software AMDIS \[[@b42-marinedrugs-09-02438]\] was used for peak identification and deconvolution of the chromatogram. This method calculates and retrieves pure (background-free) mass spectra from raw GC-MS data files based from the parameters indicated by the user. The following parameters were used for all of the analyses: medium shape requirement, medium sensitivity, and medium resolution. The ELU files generated from AMDIS were submitted for analysis using Spectconnect \[[@b43-marinedrugs-09-02438]\] to generate matrices of component peaks (relative abundance, retention time, integrated signal and base peak).

### 3.4.3. Compound Identification

In the absence of pure standards of compounds previously isolated from *Portieria* (except for β-myrcene), we used KI's, freely available mass spectral databases to determine identity of component peaks, and literature. We computed the Kovat's or retention index of each peak using the retention times of alkane standards C8--C20 and the Retention Index Calculator \[[@b32-marinedrugs-09-02438]\]. The retention index is derived from the interpolation (usually logarithmic), relating the adjusted retention volume (time) of the sample component to the adjusted retention volumes (times) of two standards eluted before and after the peak of a sample component (IUPAC definition). The calculated KI was automatically compared to the KI's of compounds stored in the built-in library of the calculator. Mass spectra of component peaks were compared to compounds retrieved from MassBank \[[@b44-marinedrugs-09-02438]\], Pherobase \[[@b45-marinedrugs-09-02438]\] and the limited version of the NIST library in the MS Search Program and AMDIS. Mass spectra of components were inspected for similarity with those of the characteristic mass signals of components published in \[[@b11-marinedrugs-09-02438],[@b12-marinedrugs-09-02438],[@b33-marinedrugs-09-02438]\].

### 3.4.4. Data Standardization, Metabolite Fingerprinting and Multivariate Analyses

Relative abundance matrices generated from the Spectconnect analyses were used for statistical analyses. A matrix contains relative abundance values of all detected components across all samples included in the analysis. The data were standardized by obtaining a ratio between the relative abundance of a component per replicate (or sample) and the total of all components per replicate (or sample). The ratios obtained among the technical replicates were subsequently averaged. Principal component analysis was performed using Statistica 7.0 (StatSoft Inc., Tulsa, OK, USA) on each dataset to detect any pattern or groupings based from the variables which are the component compounds.

4. Conclusions
==============

*Portieria* species in the Philippines are a rich source of secondary metabolites. This diversity in secondary metabolites amounts to at least 302 various compounds. The majority of which are exotic, remain undescribed and therefore are not available in natural product databases. Our study demonstrates that metabolic fingerprinting presents a practical approach to disclose intra- and interspecific patterns of secondary metabolites. Variation in secondary metabolites occurs between, as well as within, *Portieria* species. Preliminary results, based on a relatively small sample size, demonstrate that extensive intraspecific variation in secondary metabolites occurs between life-history stages. Female gametophytes (202 compounds) are chemically richer compared to that of the males (102) and tetrasporophytes (106). No spatio-temporal patterns were evident among the datasets. These results suggest that life-history driven variations and possibly other microscale factors may have an important influence on the variation of secondary metabolites within *Portieria* species. More exhaustive sampling is needed to confirm the life-stage specific metabolic fingerprints. In addition, to determine whether the intraspecific variation of the analyzed part of non-polar metabolome remains lower than the interspecific variation, it will be necessary to expand the taxon sampling across different cryptic species.

Supplementary
=============

###### 

List of compounds isolated from *Portieria* (syn. *Desmia* and *Chondrococcus*) *hornemannii*, based on previous studies.

  Reference                         Cpd \#   Name                                                                                                           Mol. Formula           Description                                              Specimen Source
  --------------------------------- -------- -------------------------------------------------------------------------------------------------------------- ---------------------- -------------------------------------------------------- ---------------------------------------------------
  \[[@b18-marinedrugs-09-02438]\]   1        Myrcene                                                                                                        C~10~H~16~             acyclic halogenated monoterpene                          Amami Is., Japan
                                    2        7-chloro-myrcene                                                                                               C~10~H~15~Cl           \"                                                       \"
                                    3        7-bromo-myrcene                                                                                                C~10~H~15~Br           \"                                                       \"
                                    4        (*Z*)-10-bromo-myrcene                                                                                         C~10~H~15~Br           \"                                                       \"
                                    5        (*E*)-10-bromo-myrcene                                                                                         C~10~H~15~Br           \"                                                       \"
                                    6        (*Z*)-10-bromo-7-chloro-myrcene                                                                                C~10~H~14~BrCl         \"                                                       \"
                                    7        (*E*)-10-bromo-7-chloro-myrcene                                                                                C~10~H~14~BrCl         \"                                                       \"
                                    8        3-chloro-7, (*Z*)-10-dibromo-myrcene                                                                           C~10~H~13~Br~2~Cl      \"                                                       \"
                                    9        (*Z*)-10-chloro-3,7-dibromo-myrcene                                                                            C~10~H~13~Br~2~Cl      \"                                                       \"
                                    10       3-bromo-7-chloro-myrcene                                                                                       C~10~H~14~BrCl         \"                                                       \"
                                    11       7-bromo-10-chloro-myrcene                                                                                      C~10~H~14~BrCl         \"                                                       \"
                                    12       \-                                                                                                             C~10~H~15~Br           cyclic halogenated monoterpene                           \"
  \[[@b19-marinedrugs-09-02438]\]   1        chondrocole A                                                                                                  C~10~H~14~BrClO        \"                                                       Hawaii
                                    2        chondrocole B                                                                                                  C~10~H~14~BrClO        \"                                                       Hawaii
  \[[@b46-marinedrugs-09-02438]\]   3        \-                                                                                                             C~10~H~15~Cl~3~Br~2~   acyclic halogenated monoterpene                          Black Point, Oahu, Hawaii
                                    4        \-                                                                                                             C~10~H~16~Cl~3~Br      \"                                                       \"
                                    5        \-                                                                                                             C~10~H~15~Cl~2~Br      \"                                                       \"
                                    6        \-                                                                                                             C~10~H~16~Cl~2~Br~2~   \"                                                       Halona Blowhole Is, Oahu, Hawaii
                                    10       \-                                                                                                             C~10~H~16~Cl~2~Br~2~   acyclic halogenated monoterpene                          \"
                                    11       6-bromo-2-chloromyrcene                                                                                        C~10~H~15~ClBr         \"                                                       Black Point, Oahu, Hawaii
                                    12       chondrocole c                                                                                                  C~10~H~14~Br~2~O       cyclic halogenated monoterpene                           \"
                                    13       \-                                                                                                             C~10~H~15~Cl~3~Br~2~   acyclic halogenated monoterpene                          Hawaii
                                    14       *Z*-3-bromomethylene-7-methyl-1,6-octadiene                                                                    C~10~H~16~ClBr~2~      \"                                                       Halona Blowhole Is., Oahu, Hawaii
                                    15       \-                                                                                                             C~10~H~14~Br~2~Cl~2~   cyclic halogenated monoterpene                           \"
  \[[@b47-marinedrugs-09-02438]\]   1        myrcene                                                                                                        C~10~H~16~             acyclic halogenated monoterpene                          Kada Coast, Wakayama Pref., Japan
                                    2        7-chloro-myrcene                                                                                               C~10~H~15~Cl           \"                                                       \"
                                    3        7-bromo-myrcene                                                                                                C~10~H~15~Br           \"                                                       \"
                                    4        3,7-dichloro-myrcene                                                                                           C~10~H~14~C~l2~        \"                                                       \"
                                    5        (*Z*)-10-bromo-3-methoxy-α-myrcene                                                                             C~11~H~17~OBr          \"                                                       \"
                                    6        (*E*)-10-bromo-3-methoxy-α-myrcene                                                                             C~11~H~17~OBr          \"                                                       \"
                                    7        3-bromo-7-chloro-myrcene                                                                                       C~10~H~14~BrCl         \"                                                       \"
                                    8        (*Z*)-10-bromo-1-methoxy-myrcene                                                                               C~11~H~17~OBr          \"                                                       \"
                                    9        (*E*)-10-bromo-1-methoxy-myrcene                                                                               C~11~H~17~OBr          \"                                                       \"
  \[[@b48-marinedrugs-09-02438]\]            (−)-3-bromomethyl-3-chloro-7-methyl-1,6-octadiene                                                              C~10~H~16~BrCl         \"                                                       Trincomalee (Foul Point) Sri Lanka
  \[[@b49-marinedrugs-09-02438]\]            2-(1-chloro-2-hydroxyethyl)-4,4-dimethylcyclohexa-2, 5-dienone: a precursor of 4,5-dimethylbenzo \[b\] furan   **-**                  **-**                                                    **-**
  \[[@b20-marinedrugs-09-02438]\]   1        (2*Z*,6*E*)-1,8-dichloro-3-chloromethyl-7-methylocta-2,6-diene                                                 C~10~H~15~Cl3          acyclic halogenated monoterpene                          Rib Reef, Great Barrier Reef, Australia
                                    2        (*E*)-1,2-dibromo-3-chloromethylene-7-methyloct-6-ene                                                          C~10~H~15~Br~2~Cl      \"                                                       \"
                                    3        (*Z*)-1-chloro-3-chloromethyl-7-methylocta-2,6-diene                                                           C~10~H~16~Cl2          \"                                                       \"
                                    4        (*Z*)-1,6-dichloro-3-chloromethyl-7-methylocta-2,7-diene                                                       C~10~H~15~Cl3          \"                                                       \"
                                    5        (2*R*\*,3(8)*E*,4*S*\*,6*R*\*)-6-bromo-2-chloro-1,4-oxido-3,(8)-ochtodene                                      C~10~H~14~BrClO        epimeric bicyclic monoterpene                            \"
                                    6        (2*S*\*,3(8)*E*,4*S*\*,6*R*\*)-6-bromo-2-chloro-1,4-oxido-3,(8)-ochtodene                                      C~10~H~14~BrClO        \"                                                       \"
  \[[@b50-marinedrugs-09-02438]\]            (*Z*)-3-bromo-8-chloro-6-chloromethyl-2-methylocta-1,6-diene (9,6-hydroxymethyl-2-methylocta-2,8-dien-6-ol     \-                     \-                                                       \-
  \[[@b21-marinedrugs-09-02438]\]   1        (2*Z*)-6-bromo-3-chloromethyl-1,7-dichloro-7-methylocta-2-ene                                                  C~10~H~16~Cl~3~Br      acyclic halogenated monoterpene                          Nelly Bay, Magnetic Island, Queensland, Australia
                                    2        (2*Z*,6*E*)-3-chloromethyl-1-chloroocta-2,6-dien-8-al                                                          C~10~H~14~OCl~2~       \"                                                       \"
                                    3        3-methoxymethyl-6-methoxyl-7-methylocta-1,7(10)-dien-3-ol                                                      C~12~H~22~ O~3~        \"                                                       \"
                                    4        (2*Z*,6*S*)-3-chloromethyl-1-methylocta-2,7(10)-dien-6-ol                                                      C~11~H~19~ O~2~Cl      \"                                                       \"
                                    5        (2*Z*,6*S*)-3-chloromethyl-6-methylocta-2,7(10)-dien-1-ol                                                      C~11~H~19~ O~2~Cl      \"                                                       \"
  \[[@b22-marinedrugs-09-02438]\]   1        **halomon/**6(*R*)-bromo-3(*S*)-(bromomethyl)-7-methyl-2,3,7-trichloro-1-octene                                C~10~H~15~Br~2~Cl~3~   acyclic halogenated monoterpene                          Chanaryan, Batan Is., Batanes, Philippines
                                    2        \-                                                                                                             C~10~H~13~Cl           cyclic halogenated monoterpene                           Banilad, Bacong, Negros Oriental, Philippines
  \[[@b23-marinedrugs-09-02438]\]   2        isohalomon                                                                                                     C~10~H~15~Br~2~Cl~3~   acyclic halogenated monoterpene; isomeric with halomon   Chanaryan, Batan Is., Batanes, Philippines
                                    3        \-                                                                                                             C~10~H~14~BrCl~3~      acyclic halogenated monoterpene                          \"
                                    4        \-                                                                                                             C~10~H~14~Br~2~Cl~2~   \"                                                       \"
                                    5        \-                                                                                                             C~10~H~14~Br~3~Cl      cyclic halogenated monoterpene                           \"
                                    6        \-                                                                                                             C~10~H~14~BrCl~3~      \"                                                       \"
                                    7        \-                                                                                                             C~10~H~13~Cl~3~        \"                                                       \"
                                    8        \-                                                                                                             C~10~H~15~BrCl~2~      acyclic halogenated monoterpene                          \"
                                    9        \-                                                                                                             C~10~H~16~Br~2~Cl~2~   \"                                                       \"
                                    10       \-                                                                                                             C~10~H~16~BrCl         \"                                                       Halona Blowhole Is, Oahu, Hawaii
                                    11       \-                                                                                                             C~10~H~15~BrCl         \"                                                       \"
                                    12       \-                                                                                                             C~10~H~14~BrCl         cyclic halogenated monoterpene                           \"
  \[[@b8-marinedrugs-09-02438]\]    1        **apakaochtodene A/**6(*S*\*)-bromo-1,4(*S*\*),8(*R*\*)-trichloro-2(Z)-ochtodene                               C~10~H~14~Cl~3~Br      cyclic halogenated monoterpene                           Apaka Point Beach, Guam
                                    2        **apakaochtodene B**/6(*S*)-bromo-1,4(*S*), 8(*R*\*)-trichloro-2(*E*)-ochtodene                                C~10~H~14~Cl~3~Br      cyclic halogenated monoterpene                           Gun Beach; Double Reef; Pago Bay; Guam
  \[[@b11-marinedrugs-09-02438]\]   1        **myrcene/**7-methyl-3-methylene-1,6-octadiene                                                                 C~10~ H~16~O           acyclic non-halogenated monoterpene                      microplantlet culture, Double Reef NW Guam
                                    2        **10*E*-bromomyrcene/***E*-3-bromomethylene-7-methyl-1,6-octadiene                                             C~10~H~15~Br           \"                                                       \"
                                    3        **10*Z*-bromomyrcene/***Z*-3-bromomethylene-7-methyl-1,6-octadiene                                             C~10~H~15~Br           \"                                                       \"
                                    4        **10*E*-bromo-3-chloro-α-myrcene/***E*-3-bromomethylene-6-chloro-1,7-octadiene                                 C~10~H~14~BrCl         \"                                                       \"
                                    5        \-                                                                                                             C~10~H~14~Br~2~        \"                                                       \"
                                    6        **apakaochtodene B/**6(*S)-*bromo*-*1,4(*S*), 8(*R*\*)-trichloro-2(*E*)-ochtodene                              C~10~H~14~BrCl~3~      cyclic halogenated monoterpene                           \"
                                    7        \-                                                                                                             C~10~ H~16~O           non-halogenated monoterpene                              \"
                                    8        bromomyrcene isomer                                                                                            C~10~H~15~Br           halogenated monoterpene                                  \"
                                    9        **7-chloromyrcene/**2-chloro-3-methylene-7-methyl-1,6-octadiene                                                C~10~H~15~Cl           \"                                                       \"
                                    10                                                                                                                      C~10~H~14~Cl           \"                                                       \"
                                    11       chloromyrcene derivative                                                                                       C~10~H~16~Cl           \"                                                       \"
                                    12       bromomyrcene isomer                                                                                            C~10~H~15~Br           \"                                                       \"
                                    13       chloromyrcene derivative                                                                                       C~10~H~14~Cl           \"                                                       \"
                                    14       \-                                                                                                             C~10~H~18~Cl~2~        \"                                                       \"
                                    15       \-                                                                                                             C~15~H~18~ O~4~        sesquiterpene                                            \"
  \[[@b13-marinedrugs-09-02438]\]   5        1,2-dibromoochtoda-3(8),5-dien-4-one                                                                           C~22~H~12~Br~2~O       cyclic halogenated monoterpene                           Cape Zampa, Okinawa, Japan
                                    6        1-bromo-2-chloroochtoda-3(8),5-dien-4-one                                                                      C~10~H~12~BrClO        \"                                                       \"
                                    7        1,2-dichloroochtoda-3(8),5-dien-4-one                                                                          C~10~H~12~Cl~2~O       \"                                                       Gushichan coast, Okinawa, Japan
                                    8        (1*Z*)-1-bromoochtoda-1,3(8),5-trien-4-one                                                                     C~10~H~11~BrO          \"                                                       Cape Zampa, Okinawa, Japan
                                    9        (1*Z*)-1-chloroochtoda-1,3(8),5-trien-4-one                                                                    C~10~H~11~ClO          \"                                                       \"
  \[[@b12-marinedrugs-09-02438]\]   1        **halomon/**6(*R*)-bromo-3(*S*)-(bromomethyl)-7-methyl-2,3,7-trichloro-1-octene                                C~10~H~15~Br~2~Cl~3~   acyclic halogenated monoterpene                          Tolagniaro, Fort Dauphin, Madagascar
                                    2        \-                                                                                                             C~10~H~13~ClBr         \"                                                       \"
                                    3        \-                                                                                                             C~10~H~14~Cl~2~Br      \"                                                       \"
                                    4                                                                                                                       C~10~H~15~Br~2~Cl~3~   \"                                                       \"

###### 

Compound peaks detected from GC-MS analysis of samples used for characterization of the life history stages of *P. hornemannii*. Identifications based on comparison of either Kovat's Indices (KI) of compounds retrieved from the Retention Index Calculator \[[@b37-marinedrugs-09-02438]\] or mass spectral comparison of compounds retrieved from NIST or MassBase. Asterisk (\*) indicates compounds with parent ions showing halogenated mass spectral patterns.

  \#               Sample   Base Peak             KI     KI Based ID   Mass Spectra Based ID                                              
  ---------------- -------- ----------- --------- ------ ------------- ------------------------------------- ---------------------------- -----------------------------------
  1                F6_2     93          6.1863    994    993/994       beta-myrcene/6-methyl-5-hepten-2-ol   b-myrcene                    b-myrcene
  2                T1_1     104         6.5874    1008   1007          α-phellandrene                        \-                           \-
  3                T1_2     104         6.5909    1008   1007          α-phellandrene                        \-                           \-
  4                M1_1     91          6.7685    1016   1017          α-terpinene                           Benzene, tert-butyl-         4-methylacetophenone
  5                F3_3     79          6.9501    1023   1024          r-cymene                              \-                           \-
  6                M1_2     79          6.9532    1023   1024          r-cymene                              \-                           \-
  7                M1_3     91          7.017     1026   1025          p-cymene                              carbonic acid                1-phenylpropan-2-one
  8                M2_2     91          7.021     1026   1025          p-cymene                              \-                           protopine
  9                F3_2     91          7.0387    1027   1025          p-cymene                              \-                           *N*-Methyl-*N*propagylbenzylamine
  10               T2_1     57          8.0381    1063   1062          y-terpinene                           \-                           \-
  11               M2_2     132         8.8894    1089   1089          p-mentha-2,4(8)diene                  \-                           \-
  12               T2_1     117         9.5127    1110   1099          linalool                              \-                           \-
  13               F4_3     117         9.8874    1124   1123          chrysanthenone                        \-                           \-
  14               M1_3     117         9.9855    1128   1127          α-campholenal                         \-                           \-
  15               M2_2     91          10.2042   1136   1127          α-campholenal                         \-                           \-
  16               F2_2     91          10.2132   1136   1127          α-campholenal                         \-                           Dimethirimol
  17               T2_1     119         10.4565   1145   1145          camphor                               \-                           Benzimidazole
  18               M1_1     68          10.8826   1160   1158          isobomeol                             \-                           \-
  19               F7_3     68          10.8845   1160   1158          isobomeol                             \-                           \-
  20               T2_1     68          10.8866   1160   1158          isobomeol                             \-                           \-
  21               F3_3     68          10.8873   1160   1158          isobomeol                             \-                           \-
  22               F4_1     117         11.3242   1174   1171          ethyl-benzoate                        \-                           \-
  23               F4_1     50          11.5177   1180   1180          m-cymen-8-ol                          \-                           \-
  24               T2_2     127         11.5317   1180   1180          m-cymen-8-ol                          \-                           \-
  25               T2_3     134         11.7619   1188   1187          p-cymen-8-ol                          \-                           \-
  26               M2_2     105         12.0654   1197   1196          methylchavicol                        \-                           3-cyanopyridine
  27               F3_2     57          12.1827   1200   1203          n-decanal                             3-Hexanone                   \-
  28               F7_3     113         12.3674   1207   1207          verbenone                             \-                           \-
  29               M1_2     113         12.3831   1208   1207          verbenone                             \-                           \-
  30               T1_3     91          12.3874   1208   1207          verbenone                             \-                           \-
  31               M2_2     93          12.6294   1217   1217          trans-carveol                         \-                           \-
  32               M1_2     69          12.7588   1222   1219          trans-carveol                         \-                           \-
  33               M1_1     55          12.8397   1225   1229          nerol                                 \-                           \-
  34               F7_3     67          13.1203   1236   1236          thymol methyl ether                   \-                           \-
  35               M1_1     79          13.1266   1236   1236          thymol methyl ether                   \-                           \-
  36               F5_2     93          13.127    1236   1236          thymol methyl ether                   \-                           Beta-pinene; y-eudesmol
  37               M2_2     93          13.32     1243   1243          carvone                               \-                           \-
  38               T1_1     93          13.327    1243   1243          carvone                               2-chloropropionyl chloride   \-
  39               T2_1     93          13.3305   1243   1243          carvone                               \-                           \-
  40 \*(Br)        F6_2     69          13.6916   1256   1256          geraniol                              \-                           \-
  41               M1_1     91          13.6953   1256   1256          geraniol                              \-                           
  42               F2_1     69          13.6967   1256   1256          geraniol                              \-                           
  43               F5_1     69          13.6975   1256   1256          geraniol                              \-                           \-
  44               M2_1     91          13.9837   1266   1263          (*E*)-2-decenal                       \-                           *N*-Methyl-*N*propagylbenzylamine
  45               F7_3     119         14.131    1271   1271          geranial                              \-                           \-
  46               F2_3     119         14.1354   1271   1271          geranial                              \-                           \-
  47               F3_2     69          14.4252   1281   1282          a-terpinen-7-al                       \-                           \-
  48               M2_3     69          14.4368   1281   1282          a-terpinen-7-al                       \-                           \-
  49               F5_1     91          14.6745   1289   1289          p-cymen-7-ol                          \-                           \-
  50               T2_1     91          14.68     1289   1289          p-cymen-7-ol                          \-                           \-
  51               F6_3     149         14.9157   1297   1297          perilla alcohol                       \-                           Benzoylcholine
  52 \* (Cl)       F6_3     131         15.0641   1302   1302          trans-ascaridole                      \-                           2-chloro-1-phenyl-2-butene
  53               F6_1     166         15.3344   1313   1313          2*E*,4*E*-decadienal                  \-                           2-chloro-1-phenyl-2-butene
  54               F6_3     81          15.5368   1320   1313          2*E*,4*E*-decadienal                  \-                           \-
  55               M2_2     81          15.5381   1321   1313          2*E*,4*E*-decadienal                  \-                           \-
  56               T1_2     81          15.5481   1321   1313          2*E*,4*E*-decadienal                  \-                           \-
  57               M2_2     67          15.6269   1324   1313          2*E*,4*E*-decadienal                  \-                           1-Adamantanamine
  58               M1_2     67          15.6354   1324   1313          2*E*,4*E*-decadienal                  \-                           \-
  59               F3_1     57          15.7447   1329   1339          d-elemene                             \-                           \-
  60               F2_1     57          15.7649   1329   1339          d-elemene                             \-                           \-
  61               M2_2     91          15.8827   1334   1339          d-elemene                             \-                           \-
  62               M1_2     91          15.8885   1334   1339          d-elemene                             \-                           \-
  63               M2_2     139         16.5157   1357   1357          eugenol                               \-                           \-
  64               F6_1     115         16.5278   1358   1357          eugenol                               \-                           \-
  65               M2_3     166         16.5392   1358   1357          eugenol                               \-                           \-
  66               M2_2     91          17.02     1375   1373          a-ylangene                            \-                           \-
  67               M2_3     91          17.0254   1376   1373          a-ylangene                            \-                           \-
  68               M1_2     91          17.0311   1376   1373          a-ylangene                            \-                           \-
  69               T2_1     127         17.403    1389   1389          isolongifolene                        \-                           Imidazole-4-acetate
  70               T2_1     57          17.7476   1400   1399          1,7-di-epi-a-cedrene                  \-                           \-
  71               M2_2     79          17.7625   1401   1402          methyleugenol                         \-                           \-
  72               M2_3     127         17.7782   1402   1402          methyleugenol                         \-                           \-
  73               T2_2     67          18.1041   1415   1415          *cis*-a-bergarnotene                  \-                           \-
  74               T1_3     79          18.18     1418   1419          β-caryophyllene                       \-                           \-
  75               F6_1     79          18.1866   1419   1419          β-caryophyllene                       \-                           \-
  76               T1_1     79          18.1928   1419   1419          β-caryophyllene                       Pyridine                     \-
  77               F5_1     79          18.1934   1419   1419          β-caryophyllene                       \-                           camphene
  78               M1_2     79          18.1939   1419   1419          β-caryophyllene                       \-                           \-
  79 \* (Br)       F7_2     212         18.3193   1424   1420          β-caroyophyllene                      \-                           \-
  80               F6_2     210         18.4564   1429   1420          β-caroyophyllene                      \-                           \-
  81               M2_3     131         18.4673   1430   1420          β-caroyophyllene                      \-                           \-
  82               M1_1     67          18.5462   1433   1435          trans-a-bergamotene                   \-                           \-
  83               M1_2     67          18.5503   1433   1435          trans-a-bergamotene                   \-                           \-
  84               F2_2     133         18.6084   1435   1435          trans-a-bergamotene                   \-                           \-
  85               T2_2     69          18.6925   1439   1438          trans-a-bergamotene                   \-                           \-
  86               F3_3     69          18.6982   1439   1440          a-guaiene                             \-                           \-
  87               M2_3     69          18.7018   1439   1440          a-guaiene                             \-                           \-
  88               M1_1     91          18.7475   1441   1440          a-guaiene                             \-                           \-
  89               F4_2     69          18.8243   1444   1440          a-guaiene                             \-                           \-
  90               F7_2     69          18.8273   1444   1440          a-guaiene                             \-                           \-
  91               T1_3     69          18.8306   1444   1440          a-guaiene                             \-                           \-
  92               F2_2     210         19.1226   1456   1455          a-humulene                            \-                           \-
  93               F3_3     133         19.3339   1464   1464          a-acoradiene                          \-                           
  94               T2_2     105         19.4843   1469   1469          drima-7,9(11)-diene                   \-                           \-
  95               T2_1     105         19.4852   1469   1469          drima-7,9(11)-diene                   \-                           \-
  96               F7_2     131         19.4915   1470   1469          drima-7,9(11)-diene                   \-                           \-
  97               F5_1     91          19.6255   1475   1474          b-cadinene                            \-                           \-
  98               F6_3     91          19.7468   1479   1479          y-curcurnene                          \-                           
  99               F2_1     91          19.7581   1480   1480          germacrene D                          \-                           \-
  100              F4_1     153         20.0567   1491   1491          *cis*-β-guaiene                       \-                           \-
  101              F4_1     153         20.0567   1491   1491          *cis*-β-guaiene                       \-                           \-
  102              F3_2     71          20.2111   1496   1495          a-zingiberene                         \-                           
  103              F7_2     135         20.3621   1502   1499          a-muurolene                           \-                           \-
  104              F5_1     91          20.3727   1503   1506          d-selinene                            \-                           \-
  105              T2_1     91          20.3766   1503   1506          d-selinene                            \-                           \-
  106              F2_2     91          20.3829   1503   1506          d-selinene                            \--                          \-
  107              F6_1     205         20.6221   1513   1513          g-cadinene                            \-                           \-
  108              F4_3     205         20.6237   1513   1513          g-cadinene                            \-                           \-
  109              F7_2     205         20.6252   1513   1513          g-cadinene                            \-                           5-bromo-4-methoxyoct-1-ene
  110              T2_1     205         20.6278   1513   1513          g-cadinene                            p-Benzoquinone               \-
  111              F3_2     133         20.6781   1516   1514          sesquicineole                         \-                           \-
  112              F3_3     133         20.6803   1516   1514          sesquicineole                         \-                           \-
  113              F6_3     133         20.685    1516   1514          sesquicineole                         \-                           \-
  114              F5_1     69          20.8293   1522   1523          d-cadinene                            \-                           \--
  115              F5_1     69          20.9154   1526   1525          eugenyl acetate                       \-                           \-
  116              F6_3     69          20.9158   1526   1525          eugenyl acetate                       \-                           \-
  117              F7_2     121         20.9204   1526   1525          eugenyl acetate                       \-                           \-
  118              T1_3     69          20.9227   1526   1525          eugenyl acetate                       \-                           \-
  119              F7_2     167         21.1103   1534   1533          cadina-1,4-diene1                     \-                           \-
  120              T2_2     91          21.1498   1536   1538          a-cadinene                            \-                           \-
  121              F6_1     167         21.43     1547   1548          elemol                                \-                           \-
  122              F7_2     167         21.4346   1547   1548          elemol                                \-                           \-
  123              T1_3     69          21.467    1549   1549          elemol                                \-                           \--
  124              F3_2     69          21.4709   1549   1549          elemol                                \-                           \-
  125              F7_2     91          21.598    1554   1552          elemicin                              \-                           \-
  126              F6_2     91          21.6852   1557   1557          germacrene B                          \-                           \-
  127              F5_1     91          21.6859   1558   1557          germacrene B                          \-                           \-
  128              F6_3     91          21.6869   1558   1557          germacrene B                          \-                           \-
  129              M1_1     91          21.6895   1558   1557          germacrene B                          \-                           \-
  130              F6_3     67          21.7268   1559   1557          germacrene B                          \-                           \-
  131              F7_2     133         21.8253   1563   1564          β-calacorene                          \-                           [l]{.smallcaps}-Asparagine
  132              T1_1     91          21.8405   1564   1564          β-calacorene                          \-                           \-
  133              F7_2     167         22.0012   1570   1574          prenopsan-8-ol                        \-                           \-
  134              T1_3     213         22.018    1571   1574          prenopsan-8-ol                        \-                           \-
  135              F6_3     132         22.0226   1571   1574          prenopsan-8-ol                        \-                           \-
  136              F6_3     153         22.0226   1571   1574          prenopsan-8-ol                        \-                           \-
  137              M1_1     91          22.3956   1586   1585          gleenol                               \-                           \-
  138              F2_2     133         22.5362   1591   1590          viridflorol                           \-                           \-
  139              F6_3     71          22.7179   1598   1590          viridflorol                           \-                           \-
  140              F3_2     71          22.7193   1598   1590          viridflorol                           \-                           \-
  141              F2_3     135         22.722    1598   1590          viridflorol                           \-                           \-
  142              F3_3     57          22.7547   1600   1607          b-oplopenone                          \-                           \-
  143              F3_2     57          22.7603   1600   1607          b-oplopenone                          \-                           \-
  144              F3_3     57          22.761    1600   1607          b-oplopenone                          \-                           \-
  145              F6_3     67          22.8782   1605   1607          b-oplopenone                          \-                           \-
  146              T2_2     68          23.0541   1613   1612          tetradecanal                          \-                           \-
  147              F4_3     148         23.2435   1622   1623          silphiperfol-6-en-5-one               \-                           \-
  148              F3_1     135         23.2485   1622   1623          silphiperfol-6-en-5-one               \-                           \-
  149              F5_3     91          23.52     1634   1633          y-eudesmol                            \-                           \-
  150              F4_3     91          23.5226   1634   1633          y-eudesmol                            \-                           \-
  151              F7_2     68          23.5261   1634   1633          y-eudesmol                            \-                           \-
  152              F7_2     68          23.5261   1634   1633          y-eudesmol                            \-                           \--
  153              T2_2     68          23.5278   1634   1633          y-eudesmol                            \-                           \-
  154              F6_1     167         23.5309   1634   1633          y-eudesmol                            \-                           
  155              F6_2     67          23.7239   1643   1642          cubenol                               \-                           allylcy-anide
  156              T1_3     91          23.8325   1647   1646          a-muurolol                            \-                           \-
  157              F7_2     132         23.8759   1649   1646          a-muurolol                            \-                           \-
  158              F7_2     132         23.9988   1654   1653          a-cadinol                             \-                           \-
  159              F6_2     149         24.3377   1669   1668          bulnesol                              \-                           \-
  160              F7_2     149         24.3428   1669   1668          bulnesol                              \-                           \-
  161              F6_3     167         24.6091   1680   1682          a-bisabolol                           \-                           \-
  162              F6_1     57          24.6252   1681   1682          a-bisabolol                           \-                           \-
  163              F7_2     69          24.8113   1689   1686          8-cedren-13-ol                        \-                           \-
  164              F7_2     69          24.8207   1689   1686          8-cedren-13-ol                        \-                           \-
  165              F2_3     67          24.9282   1693   1686          8-cedren-13-ol                        \-                           \-
  166              F6_1     57          25.0854   1700   1686          8-cedren-13-ol                        \-                           Heptadecane
  167              F7_2     91          25.3006   1710   1686          8-cedren-13-ol                        \-                           \-
  168              F3_2     71          25.3224   1711   1735          oplopanone                            \-                           \-
  169              F3_3     68          25.4814   1718   1735          oplopanone                            \-                           \-
  170              F6_3     67          25.7278   1730   1735          oplopanone                            \-                           \-
  171              F7_2     103         25.7292   1730   1735          oplopanone                            \-                           \-
  172              F2_1     67          25.7318   1730   1735          oplopanone                            \-                           \-
  173              F2_3     133         25.8305   1735   1735          oplopanone                            \-                           \-
  174              F3_1     117         25.8366   1735   1735          oplopanone                            \-                           \-
  175              F7_2     167         26.3223   1757   1761          benzyl-benzoate                       \-                           \-
  176              T2_1     167         26.5838   1769   1761          benzyl-benzoate                       \-                           6-Methylmer-captopurine
  177              F6_2     117         26.7333   1775   1789          8-a-acetoxyelemol                     \-                           \-
  178              T2_2     103         26.8111   1779   1789          8-a-acetoxyelemol                     \-                           \-
  179              F3_1     67          26.8577   1781   1789          8-a-acetoxyelemol                     \-                           \-
  180              F6_1     67          26.8599   1781   1789          8-a-acetoxyelemol                     \-                           \-
  181              F3_2     67          26.8671   1781   1789          8-a-acetoxyelemol                     \-                           \-
  182              T2_1     67          26.8697   1781   1789          8-a-acetoxyelemol                     \-                           \-
  183 \* (Cl~2~)   F6_1     103         26.8838   1782   1789          8-a-acetoxyelemol                     \-                           \-
  184              F3_1     103         26.8852   1782   1789          8-a-acetoxyelemol                     \-                           \-
  185 \* (Br)      F6_1     67          27.4286   1806   1798          nootkatone                            \-                           \-
  186 \* (Br)      F7_2     67          27.4342   1806   1798          nootkatone                            \-                           \-
  187              F2_1     67          27.4383   1807   1798          nootkatone                            \-                           \-
  188              F6_3     103         27.4961   1810   1798          nootkatone                            \-                           \-
  189              F6_1     67          27.5012   1810   1798          nootkatone                            \-                           \-
  190              F6_2     67          27.5676   1813   1827          isopropyl tetradecanoate              \-                           \-
  191              F6_2     69          28.0351   1836   1827          isopropyl tetradecanoate              \-                           \-
  192              F3_2     69          28.0387   1836   1827          isopropyl tetradecanoate              \-                           \-
  193              F6_1     91          28.3153   1849   1867          flourensiadiol                        \-                           \-
  194              F3_2     149         28.735    1869   1867          flourensiadiol                        \-                           \-
  195 \* (ClBr)    F6_2     69          29.2918   1895   1878          hexadecanol                           \-                           \-
  196              F5_3     67          29.4766   1903   1927          methyl hexadecanoate                  \-                           \-
  197              T2_1     67          29.4889   1904   1927          methyl hexadecanoate                  \-                           \-
  198              F7_2     91          30.7705   1968   1999          eicosane                              \-                           \-
  199              T2_2     91          30.7753   1969   1999          eicosane                              \-                           \-
  200              F3_2     91          30.7855   1969   1999          eicosane                              \-                           \-
  201              T2_2     64          31.6475   \-     \-            \-                                    \-                           \-
  202              T2_2     129         38.661    \-     \-            \-                                    \-                           \-

###### 

Compound peaks detected from GC-MS analysis of samples for evaluation of non-polar secondary metabolite patterns of 5 cryptic species of *P. hornemanni* found in Batanes, Philippines. Identifications based on comparison of either Kovat's Indices (KI) of compounds retrieved from the Retention Index Calculator \[[@b37-marinedrugs-09-02438]\] or mass spectral comparison of compounds retrieved from NIST or MassBase. Asterisk (\*) indicates compounds with parent ions showing halogenated mass spectral patterns.

  \#            Sample   Base Peak             KI     KI Based ID   Mass Spectra Based ID                                      
  ------------- -------- ----------- --------- ------ ------------- --------------------------- ------------------------------ -----------------------
  1             B4B      57          8.1122    1065   1062          y-terpinene                 \-                             \-
  2             B4C      69          8.7386    1085   1085          artemisia-alcohol           \-                             \-
  3             B4C      57          9.1807    1098   1097          linalool                    \-                             \-
  4             B4B      71          9.1841    1098   1097          linalool                    \-                             \-
  5             B6C      57          9.4047    1106   1099          linalool                    3-hexanone, 2,2-dimethyl-      2-methylbutane
  6             B4C      69          11.2515   1172   1171          ethyl-benzoate              \-                             \-
  7- \* (Cl)    B3A      69          11.2560   1172   1171          ethyl-benzoate              \-                             \-
  8             B4A      57          14.3547   1279   1277          trans-carvone-oxide         \-                             2,2-dimethylbutane
  9             B4B      57          14.3593   1279   1277          trans-carvone-oxide         \-                             3-ethylhexane
  10            B3B      57          14.5560   1285   1286          borneol-acetate             \-                             
  11            B3A      69          15.2678   1310   1306          undecanal                   \-                             trans-4-octene
  12            B3A      57          15.6497   1325   1314          2*E*,4*E*-decadienal        \-                             
  13            B6B      57          15.6518   1325   1314          2*E*,4*E*-decadienal        \-                             
  14            B4A      71          16.5884   1360   1357          eugenol                     \-                             2-methylpentane
  15            B6C      57          17.8154   1403   1403          italicene                   \-                             2,2-dimethylbutane
  16            B3A      57          17.8289   1404   1403          italicene                   \-                             
  17            B10      71          20.306    1500   1499          a-muurolene                 \-                             Pentacosane
  18            B3A      57          20.4025   1504   1506          d-selinene                  \-                             tripropylamine
  19            B4A      191         20.715    1517   1514          sesquicineole               \-                             
  20            B6C      57          21.0008   1529   1532          cadina-1,4-diene            \-                             
  21- \* (Br)   B3B      57          21.0024   1529   1532          cadina-1,4-diene            \-                             1-octene
  22            B4A      69          21.5566   1552   1552          elemicin                    \-                             
  23            B4A      57          25.1819   1704   1686          8-cedren-13-ol              \-                             
  24            B4B      71          25.4142   1715   1735          oplopanone                  \-                             Hexacosane
  25            B4B      69          26.0498   1745   1747          6*S*-7*R*-bisabolone        \-                             10-methyl-1-dodecanol
  26            B4A      57          27.4031   1805   1798          nootkatone                  \-                             4-methyl-1-pentene
  27            B3B      57          27.9515   1832   1827          isopropyl-tetradecanoate    \-                             2,4-dimethylpentane
  28            B3B      71          29.9932   1930   1927          methyl-hexadecanoate        \-                             docosane
  29            B6B      57          30.4182   1951   1927          methyl-hexadecanoate        \-                             \-
  30            B10      69          30.5987   1960   1927          methyl-hexadecanoate        \-                             \-
  31            B4C      73          30.6949   1965   1999          eicosane                    \-                             \-
  32            B6B      71          32.0267   \-     \-            3-hexanone, 2,2-dimethyl-   2,2-dimethylbutane             
  33            B3B      71          32.0458   \-     \-            \-                          2,2-dimethylbutane             
  34            B6B      69          34.1452   \-     \-            \-                          docosane                       
  35            B3B      69          34.7128   \-     \-            \-                          \-                             
  36            B4C      69          34.7233   \-     \-            \-                          \-                             
  37            B6C      71          35.0713   \-     \-            \-                          \-                             
  38            B3C      71          36.7162   \-     \-            \-                          3-ethylpentane                 
  39            B9B      395         38.2697   \-     \-            \-                          \-                             
  40            B6C      71          38.8875   \-     \-            \-                          3-ethylhexane                  
  41            B6B      71          39.0147   \-     \-            \-                          \-                             
  42            B4C      57          39.4792   \-     \-            \-                          3-ethylhexane                  
  43            B6B      57          39.4822   \-     \-            \-                          3,3-dimethyl-1-butene          
  44            B4C      71          39.6266   \-     \-            \-                          3-ethylpentane                 
  45            B3C      71          39.7884   \-     \-            \-                          \-                             
  46            B6B      57          40.4997   \-     \-            3-hexanone, 2,2-dimethyl-   2-methylbutane                 
  47            B6C      57          40.7684   \-     \-            \-                          3-ethylpentane                 
  48            B3C      71          40.7722   \-     \-            \-                          \-                             
  49            B4C      57          43.09     \-     \-            \-                          3-ethylpentane                 
  50            B6B      57          43.0982   \-     \-            \-                          2,2,4,6,6-pentamethylheptane   
  51            B6C      85          43.2865   \-     \-            \-                          2-methylnonane                 
  52            B6B      71          43.3628   \-     \-            \-                          3-ethylpentane                 
  53            B3C      71          43.3691   \-     \-            \-                          \-                             
  54            B3B      85          43.7727   \-     \-            \-                          3,3-dimethyl-1-butene          
  55            B4B      85          44.3901   \-     \-            \-                          Amitrole                       
  56            B6B      71          44.3953   \-     \-            \-                          3-aminopropiononitrile         
  57            B4A      71          46.2638   \-     \-            \-                          \-                             
  58            B3C      71          46.8143   \-     \-            \-                          2,3-dimethylbutane             
  59            B6B      71          46.822    \-     \-            3-hexanone, 2,2-dimethyl-   \-                             
  60            B6C      71          47.3544   \-     \-            \-                          \-                             
  61            B4A      71          47.7467   \-     \-            \-                          3-ethylypentane                
  62            B3A      57          47.7529   \-     \-            \-                          3,3-dimethyl-1-butene          
  63            B4A      71          48.0072   \-     \-            \-                          \-                             
  64            B6B      71          48.0159   \-     \-            \-                          \-                             
  65            B6C      71          48.0169   \-     \-            \-                          \-                             
  66            B4A      71          48.0321   \-     \-            \-                          \-                             
  67            B4B      71          50.7731   \-     \-            \-                          \-                             

###### 

Compound peaks detected from GC-MS analysis of samples used for evaluation of temporal and spatial patterns of non-polar metabolites of three cryptic species of *P. hornemanni* found in the Visayas. Identifications based on comparison of either Kovat's Indices (KI) of compounds retrieved from the Retention Index Calculator \[[@b37-marinedrugs-09-02438]\] or mass spectral comparison of compounds retrieved from NIST or MassBase. Asterisk (\*) indicates compounds with parent ions showing halogenated mass spectral patterns.

  \#   Sample   Base Peak             KI     KI Based ID                              Mass Spectra Based ID
  ---- -------- ----------- --------- ------ ------------- -------------------------- -------------------------
  1    3A       57          8.1118    1065   1062          y-terpinene                undecane
  2    15A      57          14.556    1285   1286          borneol acetate            1-nonene
  3    9A       57          14.556    1285   1286          borneol acetate            pentacosane
  4    29A      57          20.3128   1500   1499          a-muurolene                tricosane
  5    15B      71          20.5458   1510   1509          β-bisabolene               3-ethylpentane
  6    15A      57          25.186    1705   1686          8-cedren-13-ol             \-
  7    34A      57          25.4206   1716   1735          oplopanone                 \-
  8    15B      71          26.6674   1772   1761          benzyl-benzoate            2-methylbutane
  9    15A      57          27.8534   1827   1827          isopropyl tetradecanoate   
  10   44BB     71          30.0015   1930   1927          methyl hexadecanoate       docosane
  11   8B       57          30.4069   1950   1927          methyl hexadecanoate       
  12   15B      71          31.6111   \-     \-            \-                         \-
  13   15A      57          31.8326   \-     \-            \-                         \-
  14   15B      57          31.8342   \-     \-            \-                         1,4-dimethylhexane
  15   44BA     71          34.1535   \-     \-            \-                         docosane
  16   15B      71          34.2967   \-     \-            \-                         3-ethylpentane
  17   15A      57          34.76     \-     \-            \-                         1-octene
  18   15A      71          35.4496   \-     \-            \-                         2-methylbutane
  19   15B      57          35.5757   \-     \-            \-                         \-
  20   15B      57          35.5757   \-     \-            \-                         2,2-dimethylbutane
  21   44BA     71          37.9407   \-     \-            \-                         docosane
  22   15B      410         38.2743   \-     \-            \-                         \-
  23   15A      71          39.3484   \-     \-            \-                         3-ethylhexane
  24   15A      71          40.0877   \-     \-            \-                         2,2-dimethylbutane
  25   15A      71          40.0981   \-     \-            \-                         beta-Aminopropionitrile
  26   15B      71          42.5358   \-     \-            \-                         2-methylbutane
  27   15B      57          43.9626   \-     \-            \-                         4-methyloctane
  28   44C      71          44.6454   \-     \-            \-                         \-
  29   15A      57          45.2255   \-     \-            \-                         2,2-dimethylbutane
  30   15A      71          47.3529   \-     \-            \-                         \-
  31   15B      57          47.3534   \-     \-            \-                         \-
  32   15B      57          47.3581   \-     \-            \-                         2,4-dimethylpentane
  33   15A      71          47.6237   \-     \-            \-                         2,4-dimethylhexane

###### 

Map of sampling sites. (**a**) Map of the Philippines indicating location of Batanes and Visayas; (**b**) Sampling sites in Batan and Sabtang Islands in Batanes; (**c**) Sampling sites in Siquijor, Negros, and Cebu Islands in the Visayas).
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![Phylogenetic tree reconstructed using Bayesian inference based on the mitochondrial *cox*2--3 spacer of *Portieria* specimens collected from Batanes (B) and Visayas (V) Islands in the Philippines. Branch support (posterior probabilities) ≥ 0.5 are indicated at the branches. The eleven clades represent cryptic lineages, likely equivalent to species. Species B34 and B38 were not included in the chemical analysis.](marinedrugs-09-02438f1){#f1-marinedrugs-09-02438}

![Portion of GC-MS total ion chromatograms of non-polar extracts of *Portieria* samples: (**a**) male gametophyte from Bantayan (Dumaguete), V1; (**b**) White Beach, Batanes, B21; (**c**) Liloan, V32. β-myrcene, a precursor of many halogenated monoterpenes, was detected only in the Bantayan specimens. Naphthalene is used as an internal standard.](marinedrugs-09-02438f2){#f2-marinedrugs-09-02438}

![Frequency distribution indicating number of shared and unique non-polar secondary metabolites: (**a**) within life-history stage of species V1B from Bantayan, female (F), male (M) and tetrasporophyte (T); (**b**) among sites of species V32 collected in Sawang (SAW), Liloan (LIL) and Pagubagubaan (PAG).](marinedrugs-09-02438f3){#f3-marinedrugs-09-02438}

![Principal component analysis of GC-MS standardized relative abundance datasets which includes the compounds detected in a 67-min run of *Portieria* extracts. (**a**) Male gametophyte (M1-2) samples are clearly discriminated occurring at the positive end of the plane while female gametophyte (F2-7) and tetrasporophyte samples (T1-2) are only partially discriminated by Factor 1; (**b**) Batanes dataset includes five cryptic species. The clustering of B35 replicates and the scattered pattern of B5 suggest variation in component compounds exists between species but at the same time suggested that variation within species can occur.](marinedrugs-09-02438f4){#f4-marinedrugs-09-02438}

###### 

Principal component analysis of GC-MS standardized relative abundance datasets for detecting possible spatial and temporal patterns in: (**a**) the Visayas species; (**b**) the Visayas samples belonging to species V32. Letters indicate sampling site (DAP: Dapdap; PAG: Pagubagubaan; SAW: Sawang; SIA: Siaton) and numbers indicate month and year of sampling.
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###### 

Frequency of compounds that are unique to or common to several species of *Portieria* found in Batanes. Values in parenthesis indicate total number of compounds found in a species, while 1 indicates presence and 0 absence of a compound.

  B21 (49)   B33 (51)   B35 (60)   B8 (57)   B5 (57)   Frequency (67)
  ---------- ---------- ---------- --------- --------- ----------------
  0          0          0          1         0         1
  0          0          1          1         0         3
  0          0          1          1         1         3
  0          1          0          0         0         1
  0          1          0          1         0         2
  0          1          1          1         0         1
  0          1          1          1         1         7
  1          0          1          0         1         3
  1          0          1          1         0         2
  1          0          1          1         1         4
  1          1          0          0         1         2
  1          1          0          1         1         1
  1          1          1          0         1         4
  1          1          1          1         1         33
